Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""De Deyn, P."" wg kryterium: Autor


Tytuł:
Plasma proteome profiling identifies changes associated to AD but not to FTD.
Autorzy:
Mofrad RB; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.; Alzheimer Center and Department of Neurology Amsterdam, Department of Neurology, Neuroscience Campus Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Del Campo M; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.; Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Peeters CFW; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Mathematical and Statistical Methods Group (Biometris), Wageningen University and Research Wageningen, Wageningen, The Netherlands.
Meeter LHH; Alzheimer Center Erasmus MC and Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Seelaar H; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Koel-Simmelink M; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
Ramakers IHGB; Alzheimer Center Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Middelkoop HAM; Institute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, the Netherlands.; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
De Deyn PP; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.; Department of Neurology and Alzheimer Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Claassen JAHR; Department of Geriatric Medicine, Radboud University Medical Center, Radboudumc Alzheimer Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
van Swieten JC; Alzheimer Center Erasmus MC and Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Bridel C; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
Hoozemans JJM; Department of Pathology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands.
Scheltens P; Alzheimer Center and Department of Neurology Amsterdam, Department of Neurology, Neuroscience Campus Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van der Flier WM; Alzheimer Center and Department of Neurology Amsterdam, Department of Neurology, Neuroscience Campus Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Pijnenburg YAL; Alzheimer Center and Department of Neurology Amsterdam, Department of Neurology, Neuroscience Campus Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Teunissen CE; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC, Vrije Universiteit Amsterdam, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2022 Oct 22; Vol. 10 (1), pp. 148. Date of Electronic Publication: 2022 Oct 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Frontotemporal Dementia*/diagnosis
Frontotemporal Dementia*/genetics
Frontotemporal Lobar Degeneration*/diagnosis
Frontotemporal Lobar Degeneration*/pathology
Pick Disease of the Brain*
Humans ; Female ; Middle Aged ; Aged ; Male ; Proteome ; Proteomics ; Biomarkers
Czasopismo naukowe
Tytuł:
Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among descendants of people with dementia: a qualitative study using focus group discussions.
Autorzy:
Vrijsen J; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, FA40, PO Box 30 001, 9700, RB, Groningen, the Netherlands. .
Maeckelberghe ELM; Wenckebach Institute for Training and Education, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Broekstra R; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, FA40, PO Box 30 001, 9700, RB, Groningen, the Netherlands.; Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
de Vries JJ; Department of Neurology and Alzheimer Centre Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Abu-Hanna A; Department of Medical Informatics, University of Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
De Deyn PP; Department of Neurology and Alzheimer Centre Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Voshaar RCO; Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Reesink FE; Department of Neurology and Alzheimer Centre Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Buskens E; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, FA40, PO Box 30 001, 9700, RB, Groningen, the Netherlands.
de Rooij SE; Department of Internal Medicine & Geriatrics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Smidt N; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, FA40, PO Box 30 001, 9700, RB, Groningen, the Netherlands.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2021 Jul 07; Vol. 21 (1), pp. 1344. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dementia*/prevention & control
Adult ; Attitude ; Female ; Focus Groups ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Middle Aged ; Qualitative Research ; Risk Reduction Behavior
Czasopismo naukowe
Tytuł:
The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer's Disease.
Autorzy:
Sorgdrager F; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Der Ley CP; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Faassen M; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Calus E; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Nollen EA; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kema IP; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Dam D; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
De Deyn PP; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.; Department of Neurology, Memory Clinic of Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.
Pokaż więcej
Źródło:
International journal of tryptophan research : IJTR [Int J Tryptophan Res] 2020 Dec 28; Vol. 13, pp. 1178646920972657. Date of Electronic Publication: 2020 Dec 28 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
Autorzy:
Chapuis J; 1] INSERM U744, Université Lille Nord de France, Institut pasteur de Lille, Lille, France [2] Université Lille Nord de France, Institut pasteur de Lille, Lille, France [3] Université Lille-Nord de France, Institut pasteur de Lille, Lille, France.
Hansmannel F
Gistelinck M
Mounier A
Van Cauwenberghe C
Kolen KV
Geller F
Sottejeau Y
Harold D
Dourlen P
Grenier-Boley B
Kamatani Y
Delepine B
Demiautte F
Zelenika D
Zommer N
Hamdane M
Bellenguez C
Dartigues JF
Hauw JJ
Letronne F
Ayral AM
Sleegers K
Schellens A
Broeck LV
Engelborghs S
De Deyn PP
Vandenberghe R
O'Donovan M
Owen M
Epelbaum J
Mercken M
Karran E
Bantscheff M
Drewes G
Joberty G
Campion D
Octave JN
Berr C
Lathrop M
Callaerts P
Mann D
Williams J
Buée L
Dewachter I
Van Broeckhoven C
Amouyel P
Moechars D
Dermaut B
Lambert JC
Pokaż więcej
Corporate Authors:
GERAD consortium
Źródło:
Molecular psychiatry [Mol Psychiatry] 2013 Nov; Vol. 18 (11), pp. 1225-34. Date of Electronic Publication: 2013 Feb 12.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptor Proteins, Signal Transducing/*genetics
Alzheimer Disease/*genetics
Alzheimer Disease/*pathology
Genetic Predisposition to Disease/*genetics
Nuclear Proteins/*genetics
Tumor Suppressor Proteins/*genetics
tau Proteins/*metabolism
Adaptor Proteins, Signal Transducing/biosynthesis ; Alzheimer Disease/metabolism ; Animals ; Brain/metabolism ; Brain/pathology ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Case-Control Studies ; Cells, Cultured ; Drosophila Proteins/deficiency ; Drosophila Proteins/genetics ; Drosophila Proteins/metabolism ; Drosophila melanogaster/genetics ; Drosophila melanogaster/metabolism ; Endophenotypes ; Gene Expression/genetics ; Humans ; Mice ; Nerve Degeneration/genetics ; Nerve Degeneration/pathology ; Nuclear Proteins/biosynthesis ; Plaque, Amyloid/pathology ; Polymorphism, Single Nucleotide/genetics ; Synaptosomes/pathology ; Transcription Factors/deficiency ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Tumor Suppressor Proteins/biosynthesis ; tau Proteins/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse.
Autorzy:
Lee EK; Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA 90095-7054, USA.
Hu C
Bhargava R
Ponnusamy R
Park H
Novicoff S
Rozengurt N
Marescau B
De Deyn P
Stout D
Schlichting L
Grody WW
Cederbaum SD
Lipshutz GS
Pokaż więcej
Źródło:
Gene therapy [Gene Ther] 2013 Aug; Vol. 20 (8), pp. 785-96. Date of Electronic Publication: 2013 Feb 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Genetic Therapy*
Arginase/*genetics
Hyperargininemia/*genetics
Nervous System Diseases/*genetics
Neurodegenerative Diseases/*genetics
Animals ; Arginase/metabolism ; Dependovirus ; Disease Models, Animal ; Humans ; Hyperammonemia/genetics ; Hyperammonemia/pathology ; Hyperammonemia/therapy ; Hyperargininemia/pathology ; Hyperargininemia/therapy ; Mice ; Mice, Transgenic ; Nervous System Diseases/pathology ; Nervous System Diseases/therapy ; Neurodegenerative Diseases/pathology ; Neurodegenerative Diseases/therapy
Czasopismo naukowe
Tytuł:
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.
Autorzy:
Lambert JC; Unité INSERM 744, Institut Pasteur de Lille BP 245,1, rue du professeur Calmette, F59019Lille cedex, France. />Sleegers K
González-Pérez A
Ingelsson M
Beecham GW
Hiltunen M
Combarros O
Bullido MJ
Brouwers N
Bettens K
Berr C
Pasquier F
Richard F
Dekosky ST
Hannequin D
Haines JL
Tognoni G
Fiévet N
Dartigues JF
Tzourio C
Engelborghs S
Arosio B
Coto E
De Deyn P
Del Zompo M
Mateo I
Boada M
Antunez C
Lopez-Arrieta J
Epelbaum J
Schjeide BM
Frank-Garcia A
Giedraitis V
Helisalmi S
Porcellini E
Pilotto A
Forti P
Ferri R
Delepine M
Zelenika D
Lathrop M
Scarpini E
Siciliano G
Solfrizzi V
Sorbi S
Spalletta G
Ravaglia G
Valdivieso F
Vepsäläinen S
Alvarez V
Bosco P
Mancuso M
Panza F
Nacmias B
Bossù P
Hanon O
Piccardi P
Annoni G
Mann D
Marambaud P
Seripa D
Galimberti D
Tanzi RE
Bertram L
Lendon C
Lannfelt L
Licastro F
Campion D
Pericak-Vance MA
Soininen H
Van Broeckhoven C
Alpérovitch A
Ruiz A
Kamboh MI
Amouyel P
Pokaż więcej
Źródło:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2010; Vol. 22 (1), pp. 247-55.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*epidemiology
Alzheimer Disease/*genetics
Calcium Channels/*genetics
Membrane Glycoproteins/*genetics
Polymorphism, Genetic/*genetics
Age of Onset ; Aged ; Aged, 80 and over ; Alleles ; Apolipoprotein E4/genetics ; Apolipoprotein E4/metabolism ; Calcium Channels/metabolism ; Case-Control Studies ; Female ; Humans ; Male ; Membrane Glycoproteins/metabolism ; Middle Aged
Czasopismo naukowe
Tytuł:
Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment.
Autorzy:
Dierckx E; Developmental and Lifespan Psychology, Vrije Universiteit Brussel, Brussels, Belgium. />Engelborghs S
De Raedt R
Van Buggenhout M
De Deyn PP
Verté D
Ponjaert-Kristoffersen I
Pokaż więcej
Źródło:
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2009 Oct; Vol. 24 (10), pp. 1094-100.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cues*
Mental Recall*
Alzheimer Disease/*diagnosis
Cognition Disorders/*diagnosis
Aged ; Alzheimer Disease/psychology ; Cognition Disorders/psychology ; Disease Progression ; Female ; Humans ; Logistic Models ; Male ; Neuropsychological Tests ; Predictive Value of Tests ; Prospective Studies ; Severity of Illness Index ; Surveys and Questionnaires ; Verbal Learning
Czasopismo naukowe
Tytuł:
FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis.
Autorzy:
Errijgers V; Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.
Van Dam D
Gantois I
Van Ginneken CJ
Grossman AW
D'Hooge R
De Deyn PP
Kooy RF
Pokaż więcej
Źródło:
Genes, brain, and behavior [Genes Brain Behav] 2007 Aug; Vol. 6 (6), pp. 552-7. Date of Electronic Publication: 2006 Nov 03.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mice, Mutant Strains*
Behavioral Research/*methods
Evoked Potentials, Visual/*physiology
Maze Learning/*physiology
Monophenol Monooxygenase/*metabolism
Albinism/enzymology ; Albinism/genetics ; Animals ; Crosses, Genetic ; Cyclic GMP/genetics ; Cyclic GMP/metabolism ; Exploratory Behavior ; Eye/anatomy & histology ; Eye/enzymology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred Strains ; Mice, Transgenic ; Models, Animal ; Monophenol Monooxygenase/genetics ; Pigmentation/genetics ; Pigmentation/physiology ; Retinal Degeneration/enzymology ; Retinal Degeneration/genetics ; Species Specificity
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies